人胰淀素对糖尿病脂代谢调控的研究进展(4)
[27] Gebre -Medhin S， Mulder H， Pekny M ， et al. Increased insulin secretion and glucose tolerance in mice lacking islet Amyloid polypeptide(Amylin)[J].Biochem Biophys Res Commum，1998，250(2)：271-275.
[28] 高燕燕，楊青，杨利波，等.单纯性肥胖患者血清胰淀素水平与体成分的相关性研究[J].山东大学学报，2006， 44(5)：443-446.
[29] Hollander P， Ratner R， Fineman M， et al.Addition of pramlintide to insulin therapy lowers HbA1c in conjunction with weight loss in patients with type 2 diabetes approaching glycaemic targets[J].Diabetes Obes Metab，2003，5(6)：408-414.
[30] Ratner RE， Dickey R， Fineman M， et al. Amylin replacement with pramlintide as an adjunct to insulin therapy improves long-term glycaemic and weight control in type 1 diabetes mellitus： a 1-year， randomized controlled trial[J]. Diabet Med，2004，21(11)：1204-1212.
[31] Boyle CN， Lutz TA ， Foll CL. Amylin-Its role in the homeostatic and hedonic control of eating and recent developments of amylin analogs to treat obesity[J].Molecular Metabolism，2017，8(c).
(收稿日期：2017-11-25), http://www.100md.com(陈妙玲 黄静 韩靖涛 陆琪 覃高升 张晓溪)
[28] 高燕燕，楊青，杨利波，等.单纯性肥胖患者血清胰淀素水平与体成分的相关性研究[J].山东大学学报，2006， 44(5)：443-446.
[29] Hollander P， Ratner R， Fineman M， et al.Addition of pramlintide to insulin therapy lowers HbA1c in conjunction with weight loss in patients with type 2 diabetes approaching glycaemic targets[J].Diabetes Obes Metab，2003，5(6)：408-414.
[30] Ratner RE， Dickey R， Fineman M， et al. Amylin replacement with pramlintide as an adjunct to insulin therapy improves long-term glycaemic and weight control in type 1 diabetes mellitus： a 1-year， randomized controlled trial[J]. Diabet Med，2004，21(11)：1204-1212.
[31] Boyle CN， Lutz TA ， Foll CL. Amylin-Its role in the homeostatic and hedonic control of eating and recent developments of amylin analogs to treat obesity[J].Molecular Metabolism，2017，8(c).
(收稿日期：2017-11-25), http://www.100md.com(陈妙玲 黄静 韩靖涛 陆琪 覃高升 张晓溪)